VIT 2.70% 7.6¢ vitura health limited

DCF valuation is $3 plus...., page-4

  1. 1,796 Posts.
    lightbulb Created with Sketch. 2
    also look at LNK group recent ipo. it just met prospectus like VIT also. market didnt hammer it. it is coz its a large cap over $2bn market cap and index funds have to hold. But its growth prospects appear average at best over the long term compared to VIT. still it is 16% above the issue price shows VIT is harshly treated. LNK was a lot higher p/e at 24p/e at the issue price, now its 28 p/e...

    So VIT is getting punished due to general sector uncertainty(whether real or perceived- all noise imho - chinese govt aint stopping the grey market at all). Also weak technicals doesn't help, people dont like a downtrend, but that doesnt mean that it should head to zero(large downward trend of acceleration suggests it is going insolvent which it is clearly not)
    Last edited by tbecker101: 27/02/16
 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.